Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Accenture
Daiichi Sankyo
US Department of Justice
Covington
Federal Trade Commission
Colorcon
McKesson
Harvard Business School

Generated: December 12, 2017

DrugPatentWatch Database Preview

Cnty Line Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CNTY LINE PHARMS, and what generic alternatives to CNTY LINE PHARMS drugs are available?

CNTY LINE PHARMS has thirteen approved drugs.

There are two US patents protecting CNTY LINE PHARMS drugs.

There are forty-one patent family members on CNTY LINE PHARMS drugs in thirty-four countries.

Summary for Cnty Line Pharms

International Patents:41
US Patents:2
Tradenames:11
Ingredients:9
NDAs:13
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Cnty Line PharmsCICLOPIROXciclopiroxGEL;TOPICAL020519-001Jul 21, 1997ABRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-002Aug 1, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsDYNACINminocycline hydrochlorideCAPSULE;ORAL063067-002Sep 15, 1999ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsLIDEXfluocinonideOINTMENT;TOPICAL016909-002Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsDYNACINminocycline hydrochlorideCAPSULE;ORAL063067-001Jul 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsBUTALBITAL AND ACETAMINOPHENacetaminophen; butalbitalTABLET;ORAL205120-001Oct 30, 2015AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-001May 24, 1985ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL204772-002Feb 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-003Aug 1, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cnty Line PharmsMETHYLPHENIDATE HYDROCHLORIDEmethylphenidate hydrochlorideTABLET;ORAL206840-002Sep 15, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-001May 24, 1985► Subscribe► Subscribe
Cnty Line PharmsTAMBOCORflecainide acetateTABLET;ORAL018830-002Oct 31, 1985► Subscribe► Subscribe
Cnty Line PharmsTAMBOCORflecainide acetateTABLET;ORAL018830-004Aug 23, 1988► Subscribe► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-002Aug 1, 1984► Subscribe► Subscribe
Cnty Line PharmsTAMBOCORflecainide acetateTABLET;ORAL018830-002Oct 31, 1985► Subscribe► Subscribe
Cnty Line PharmsTAMBOCORflecainide acetateTABLET;ORAL018830-003Jun 3, 1988► Subscribe► Subscribe
Cnty Line PharmsLIDEXfluocinonideCREAM;TOPICAL016908-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-003Aug 1, 1984► Subscribe► Subscribe
Cnty Line PharmsTRANDATElabetalol hydrochlorideTABLET;ORAL018716-004Aug 1, 1984► Subscribe► Subscribe
Cnty Line PharmsTAMBOCORflecainide acetateTABLET;ORAL018830-004Aug 23, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expirations for CNTY LINE PHARMS

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

International Patent Family for Cnty Line Pharms Drugs

Country Document Number Estimated Expiration
Yugoslavia13599► Subscribe
Hungary228297► Subscribe
Argentina008858► Subscribe
Czech Republic9901073► Subscribe
Turkey9900723► Subscribe
Australia718837► Subscribe
European Patent Office0928192► Subscribe
South Africa9708638► Subscribe
Poland332604► Subscribe
Spain2176702► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Dow
Citi
Mallinckrodt
Novartis
Colorcon
Cantor Fitzgerald
Harvard Business School
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot